查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678545

皮下避孕植入市場規模、佔有率、趨勢分析報告：依產品、通路、地區、細分市場預測，2025-2030 年

Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report By Product (Etonogestrel Implant, Levonorgestrel Implant), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

皮下避孕植入市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球皮下避孕植入市場規模預計到2030年將達到17.4億美元，預計2025年至2030年期間的複合年成長率為7.61%。

市面上出現了多種現代避孕藥物，人們對各種避孕方法的認知不斷提高，以及人均收入較高，是推動避孕皮下植入市場發展的一些主要因素。

根據古特馬赫研究所統計，2014 年約有 2,000 萬名女性需要公共資助的避孕服務。根據美國疾病管制與預防中心統計，2017 年，美國約有 4,690 萬名女性使用至少一種避孕方法。皮下植入是女性的長期避孕方法。皮下避孕植入為聚合物膠囊或棒狀物，插入皮下。孕酮以緩慢而穩定的速度釋放，可提供一至五年的有效避孕效果。

公共資助的計劃生育服務幫助婦女避免懷孕或計劃懷孕。 2012 年，南卡羅來納州衛生與公眾服務部 (SCDHHS) 修改了產後不久植入長效可逆避孕藥 (LARC) 的醫療補助付款政策。根據這項新的付款政策，服務提供者除了可以使用診斷相關群組 (DRG) 之外，還可以使用帶有計劃生育修飾符的 J 代碼來收取插入手術費用以及子宮內避孕器或植入的費用。

植入是撒哈拉以南非洲地區婦女最廣泛使用的避孕方法。這要歸功於製造商、捐助者、政府和國際組織之間的官民合作關係關係，這些合作夥伴關係有助於降低商品成本並提高產品供應量。南非、馬拉威和盧安達的避孕器使用率正在增加。根據 PLOS.org 報導，2016 年馬拉威都市區的長效可逆避孕 (LARC) 使用率達 10.21%，農村地區的使用率達 9.66%。 2012年，一項名為「2020計劃生育」（FP2020）的計劃啟動，旨在確保到2020年有1.2億女性能夠獲得現代避孕措施。

皮下避孕植入市場報告重點

  • 依托孕烯植入將佔據市場主導地位，到 2024 年將佔 64.73% 的佔有率。促進因素是意外懷孕和不安全流產的增加。
  • 醫院將主導市場，到 2024 年將佔據 54.37% 的佔有率。醫院為患者提供全面的環境，並提供包括檢查、諮詢和程序在內的廣泛服務，從而推動了該領域的成長。
  • 北美皮下避孕植入物市場佔據主導地位，2024 年的市佔率為 64.91%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 皮下避孕植入市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰與機會分析
  • 皮下避孕植入市場分析工具
    • 波特的分析
    • PESTEL 分析

第 4 章 皮下避孕植入市場：依產品分類的估計與趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年產品市場佔有率分析
  • 細分儀表板
  • 2018 年至 2030 年皮下避孕植入市場（依產品分類）
    • 依托孕烯植入
    • levonorgestrel植入

第 5 章 皮下避孕植入市場：依通路進行的估計與趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年通路市場佔有率分析
  • 細分儀表板
  • 2018 年至 2030 年皮下避孕植入市場（依通路分類）
    • 醫院
    • 婦科門診
    • 社區健康中心
    • 其他

第6章 皮下避孕植入市場：按地區分類的估計和趨勢分析

  • 定義和範圍
  • 2024 年及 2030 年區域市場佔有率分析
  • 2024 年及 2030 年皮下避孕植入各地區市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的近期趨勢及影響分析
  • 公司分類
  • 公司市場佔有率分析
  • 公司熱圖分析
  • 戰略地圖
  • 公司簡介
    • Merck & Co., Inc.
    • Shanghai Dahua Pharmaceutical Co., Ltd.
    • Bayer AG
    • Baxter
    • BD
    • Gerresheimer AG
    • Pfizer, Inc.
    • Novartis AG
    • SCHOTT
    • Lilly
Product Code: GVR-3-68038-848-0

Subdermal Contraceptive Implants Market Growth & Trends:

The global subdermal contraceptive implants market size is estimated to reach USD 1.74 billion by 2030, registering to grow at a CAGR of 7.61% from 2025 to 2030 according to a new report by Grand View Research, Inc. Introduction of several modern contraceptives in the market, growing awareness about various birth control methods, and high per capita income are some of the key factors driving the market for subdermal implants for birth control.

According to the Guttmacher Institute, in 2014, approximately 20 million women needed publicly funded contraceptive services. According to CDC, in 2017, nearly 46.9 million women in the U.S. were using at least one method of contraception. Subdermal implant is a long-term birth control option for women. Subdermal implants for contraception are in the form of polymer capsules or rods placed under the skin. The progestational hormone is released at a slow and stable rate, providing effective contraception for 1-5 years.

Publicly funded family planning services help women avoid or plan pregnancies. In 2012, the South Carolina Department of Health and Human Services (SCDHHS) revised the cost associated with Medicaid payment policy for immediate postpartum insertion of Long-Acting Reversible Contraception (LARC). Under this new reimbursement policy, providers are allowed to bill for the insertion procedure and the cost of an IUD or an implant, in addition to the Diagnosis Related Group (DRG) by using J-codes with a family planning modifier.

Implants are the most widely used contraceptive methods by women in sub-Saharan Africa owing to public-private partnerships between manufacturers, donors, governments, and international agencies, which helps lower commodity cost and increase product availability. Contraceptive usage has increased in South Africa, Malawi, and Rwanda. According to PLOS.org, in Malawi, the use of the Long-acting Reversible Contraception (LARC) method reached 10.21% in urban areas in 2016 and 9.66% in rural areas. In 2012, an initiative called Family Planning 2020 (FP2020) was launched to give 120 million women access to modern contraceptive methods by 2020.

Subdermal Contraceptive Implants Market Report Highlights:

  • Etonogestrel implants dominated the market and accounted for a share of 64.73% in 2024. The driving factors are rising unintended pregnancies and unsafe abortions.
  • Hospital dominated the market and accounted for a share of 54.37% in 2024. Hospitals provide a comprehensive environment for patients, offering a wide range of services including tests, consultations, and procedures, which drive segment growth.
  • North America subdermal contraceptive implants market dominated the market with a market share of 64.91% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Secondary Sources
    • 1.4.2. List of Primary Sources
    • 1.4.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Distribution Channel Outlook
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Subdermal Contraceptive Implants Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Awareness of family planning
      • 3.2.1.2. Demand for Long-Acting Reversible Contraceptives (LARCs)
      • 3.2.1.3. Technological advancements and product improvements
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Side effects and health concerns
    • 3.2.3. Industry Challenges and Opportunity Analysis
  • 3.3. Subdermal Contraceptive Implants Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Subdermal Contraceptive Implants Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Subdermal Contraceptive Implants Market: By Product, 2018 to 2030
    • 4.4.1. Etonogestrel Implant
      • 4.4.1.1. Etonogestrel implant market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Levonorgestrel Implant
      • 4.4.2.1. Levonorgestrel implant market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Subdermal Contraceptive Implants Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Distribution Channel Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Subdermal Contraceptive Implants Market: By Distribution Channel, 2018 to 2030
    • 5.4.1. Hospital
      • 5.4.1.1. Hospital market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Gynecology Clinics
      • 5.4.2.1. Gynecology clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Community Health Care Centers
      • 5.4.3.1. Community health care centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Subdermal Contraceptive Implants Market: Regional Estimates & Trend Analysis by Region, Product

  • 6.1. Definition and Scope
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Subdermal Contraceptive Implants Market Share, By Region, 2024 & 2030 (USD Million)
  • 6.4. North America
    • 6.4.1. North America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. U.S. Key Country Dynamics
      • 6.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Canada Key Country Dynamics
      • 6.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Mexico Key Country Dynamics
      • 6.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. UK Key Country Dynamics
      • 6.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. U.K. Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Germany Key Country Dynamics
      • 6.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. France Key Country Dynamics
      • 6.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Italy Key Country Dynamics
      • 6.5.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Spain Key Country Dynamics
      • 6.5.6.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Denmark Spain Key Country Dynamics
      • 6.5.7.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Sweden Key Country Dynamics
      • 6.5.8.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Norway Key Country Dynamics
      • 6.5.9.2. Regulatory Landscape/Reimbursement Scenario
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. China Key Country Dynamics
      • 6.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. China Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Japan
      • 6.6.3.1. Japan Key Country Dynamics
      • 6.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. Japan Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. India Key Country Dynamics
      • 6.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. South Korea Key Country Dynamics
      • 6.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Australia Key Country Dynamics
      • 6.6.6.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Thailand Key Country Dynamics
      • 6.6.7.2. Regulatory Landscape/Reimbursement Scenario
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Brazil Key Country Dynamics
      • 6.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Argentina Key Country Dynamics
      • 6.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East and Africa (MEA)
    • 6.8.1. Middle East and Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. South Africa Key Country Dynamics
      • 6.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Saudi Arabia Key Country Dynamics
      • 6.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. UAE Key Country Dynamics
      • 6.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Kuwait Key Country Dynamics
      • 6.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Share Analysis
  • 7.4. Company Heat Map Analysis
  • 7.5. Strategy Mapping
  • 7.6. Company Profiles
    • 7.6.1. Merck & Co., Inc.
      • 7.6.1.1. Participant's Overview
      • 7.6.1.2. Financial Performance
      • 7.6.1.3. Product Benchmarking
      • 7.6.1.4. Recent Developments
    • 7.6.2. Shanghai Dahua Pharmaceutical Co., Ltd.
      • 7.6.2.1. Participant's Overview
      • 7.6.2.2. Financial Performance
      • 7.6.2.3. Product Benchmarking
      • 7.6.2.4. Recent Developments
    • 7.6.3. Bayer AG
      • 7.6.3.1. Participant's Overview
      • 7.6.3.2. Financial Performance
      • 7.6.3.3. Product Benchmarking
      • 7.6.3.4. Recent Developments
    • 7.6.4. Baxter
      • 7.6.4.1. Participant's Overview
      • 7.6.4.2. Financial Performance
      • 7.6.4.3. Product Benchmarking
      • 7.6.4.4. Recent Developments
    • 7.6.5. BD
      • 7.6.5.1. Participant's Overview
      • 7.6.5.2. Financial Performance
      • 7.6.5.3. Product Benchmarking
      • 7.6.5.4. Recent Developments
    • 7.6.6. Gerresheimer AG
      • 7.6.6.1. Participant's Overview
      • 7.6.6.2. Financial Performance
      • 7.6.6.3. Product Benchmarking
      • 7.6.6.4. Recent Developments
    • 7.6.7. Pfizer, Inc.
      • 7.6.7.1. Participant's Overview
      • 7.6.7.2. Financial Performance
      • 7.6.7.3. Product Benchmarking
      • 7.6.7.4. Recent Developments
    • 7.6.8. Novartis AG
      • 7.6.8.1. Participant's Overview
      • 7.6.8.2. Financial Performance
      • 7.6.8.3. Product Benchmarking
      • 7.6.8.4. Recent Developments
    • 7.6.9. SCHOTT
      • 7.6.9.1. Participant's Overview
      • 7.6.9.2. Financial Performance
      • 7.6.9.3. Product Benchmarking
      • 7.6.9.4. Recent Developments
    • 7.6.10. Lilly
      • 7.6.10.1. Participant's Overview
      • 7.6.10.2. Financial Performance
      • 7.6.10.3. Product Benchmarking
      • 7.6.10.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 4 North America subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 5 U.S. subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 Canada subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 8 Canada subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 Mexico subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 10 Mexico subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Europe subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 12 Europe subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 UK subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 14 UK subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Germany subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 16 Germany subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 17 France subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 18 France subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Italy subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 20 Italy subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 Spain subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 22 Spain subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 23 Denmark subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 24 Denmark subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 Sweden subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 26 Sweden subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Norway subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 28 Norway subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Japan subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 32 Japan subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 33 China subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 34 China subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 35 India subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 36 India subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Australia subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 38 Australia subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 South Korea subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 40 South Korea subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 Thailand subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 42 Thailand subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Latin America subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Brazil subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 46 Brazil subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Argentina subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 48 Argentina subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 MEA subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 50 MEA subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 51 South Africa subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 52 South Africa subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 Saudi Arabia subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 54 Saudi Arabia subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 UAE subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 56 UAE subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)
  • Table 57 Kuwait subdermal contraceptive implants market estimates and forecasts by product, 2018 - 2030 (USD Million)
  • Table 58 Kuwait subdermal contraceptive implants market estimates and forecasts by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Subdermal contraceptive implants market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market snapshot
  • Fig. 7 Segment snapshot (1/2)
  • Fig. 8 Segment snapshot (2/2)
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Subdermal contraceptive implants- market size and growth prospects (USD Million)
  • Fig. 11 Subdermal contraceptive implants market: industry value chain analysis
  • Fig. 12 Subdermal contraceptive implants market: market dynamics
  • Fig. 13 Subdermal contraceptive implants market: porter's analysis
  • Fig. 14 Subdermal contraceptive implants market: pestel analysis
  • Fig. 15 Subdermal contraceptive implants market share by product 2024 & 2030 (USD Million)
  • Fig. 16 Subdermal contraceptive implants market, by product: key takeaways
  • Fig. 17 Subdermal contraceptive implants market, by product: market share, 2024 & 2030
  • Fig. 18 Etonogestrel implant market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Levonorgestrel implant market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Subdermal contraceptive implants market share by distribution channel 2024 & 2030 (USD Million)
  • Fig. 21 Subdermal contraceptive implants market, by distribution channel: key takeaways
  • Fig. 22 Subdermal contraceptive implants market, by distribution channel: market share, 2024 & 2030
  • Fig. 23 Hospital market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Gynecology clinics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Community health care centres market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Subdermal contraceptive implants market revenue, by region, 2024 & 2030 (USD Million)
  • Fig. 28 Regional marketplace: key takeaways
  • Fig. 29 Regional marketplace: key takeaways
  • Fig. 30 North america subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.s. Subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Uk subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia pacific subdermal contraceptive implants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Japan subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South korea subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin america subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Mea subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi arabia subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South africa subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Uae subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait subdermal contraceptive implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key company categorization
  • Fig. 59 Company market positioning
  • Fig. 60 Key company market share analysis, 2024
  • Fig. 61 Strategic framework